News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Celladon Corporation To Host Investor And Analyst Day And Webcast On May 6th In New York City


4/29/2014 9:26:35 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

SAN DIEGO, April 29, 2014 (GLOBE NEWSWIRE) -- Celladon Corporation (Nasdaq:CLDN), a clinical-stage biotechnology company focused on developing novel therapies by applying its leadership position in the field of SERCA enzymes, today announced that it will host an Investor and Analyst Day on Tuesday, May 6, 2014 at 8:00 a.m. in New York City. Members of Celladon's senior management team will provide a business update and an overview of the Company's strategies to drive long-term growth and will offer perspective on the recent Breakthrough Therapy Designation granted to its lead product candidate MYDICAR – the first gene therapy based product candidate to receive this designation from the Food and Drug Administration (FDA).

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES